Related Experiment Video
Updated: Mar 9, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.4K
Optimization of protocol design: a path to efficient, lower cost clinical trial execution
1Department of Surgery, Boston University, 88 East Newton street, Collamore building, Department of Surgery, Boston, MA 02118, USA.
Future Science OA
|December 30, 2016
Summary
This study introduces a scoring model to manage clinical trial complexity and costs. It offers strategies for efficient protocol development, ensuring timely delivery of crucial drug safety and efficacy data.
Area of Science:
- Clinical trial management
- Drug development
- Protocol optimization
Background:
- Effective clinical trial management is crucial for timely drug development.
- Standardized guidelines and complexity evaluation are needed for efficient trial execution.
- Challenges include patient enrollment, data collection, cost management, and protocol complexity.
Conclusions:
- Standardized guidelines and a robust scoring methodology are essential for managing clinical trial complexity.
- Strategic planning and efficient execution are key to timely delivery of trial outcomes.
- The proposed model aids in ensuring drug safety and efficacy while managing costs and risks.
Related Concept Videos
01:16Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
01:11Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
354
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
354
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
196
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
196
01:28Dosage Regimens: Designs and Approaches
411
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
411
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
347
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
347